Last updated: May 30, 2026
ANECTINE suppliers: who makes and supplies the active ingredient, finished drug, and key components for generic entry
An ectine is a brand name that is typically associated with the drug atracurium/neuromuscular blockade in many markets; however, no verifiable, authoritative sourcing profile for “ANECTINE” can be produced from the information provided. Without the exact country/market, dosage form (e.g., injection), strength, and active ingredient confirmation, supplier lists risk being inaccurate (brand-name collisions, different actives under the same trade name, and separate supply chains by region).
Which companies supply ANECTINE (atracurium) to hospitals and distributors?
Featured snippet answer: Not enough verified identifiers provided to map “ANECTINE” to specific manufacturers or finished-dose suppliers.
What supplier categories exist for ANECTINE products
- Active pharmaceutical ingredient (API) manufacturers for the relevant neuromuscular blocker
- Finished-dose sterile manufacturers (vials/ampoules, injection lines)
- Contract manufacturers for packaging and labeling by territory
- Wholesalers and hospital distribution partners by country
- Specialty distribution for cold-chain only if required by the labeled storage conditions
What suppliers make the ANECTINE injection (vial/ampoule) in the US, EU, and UK?
Featured snippet answer: No verified market-specific product identity given, so regional supplier mapping cannot be stated.
How regional identity changes supplier lists
- Trade name reuse for different actives
- Multiple strengths and presentations with different local marketing authorizations
- Separate sterile manufacturing sites approved for the same marketing authorization
- Post-authorization changes that shift supply from one packager to another
Which API manufacturers supply the active ingredient behind ANECTINE?
Featured snippet answer: Not enough information to confirm which active ingredient “ANECTINE” refers to, so API supplier attribution cannot be completed.
API supply chain inputs that drive procurement
- API polymorph and particle properties (for solid intermediates)
- Salt form and impurity profiles (critical in neuromuscular blockers)
- Sterile drug substance handling and trace impurity limits
- Compliance: DMF/CEP linkage to specific sites (varies by jurisdiction)
What excipients and sterile manufacturing suppliers are used for ANECTINE?
Featured snippet answer: No verified formulation composition (excipients) provided, so excipient and fill-finish supply cannot be listed.
Excipients and fill-finish elements that usually matter
- Buffer system and pH adjusters
- Tonicity agents
- Antioxidants or stabilizers (if present in the approved formulation)
- Container closure system (Type I glass vs polymer coated, stopper material)
- Sterile filtration and aseptic processing providers (fill-finish)
How do generics affect ANECTINE supplier eligibility and sourcing?
Featured snippet answer: Cannot be determined without knowing the active ingredient, strength, and regulatory status for the specific ANECTINE market.
Generic entry risks that change supplier choices
- Patent estate and data exclusivity for the reference product
- Orange Book (US) or national register status (EU/UK)
- DMF linkage to API sites and approved process parameters
- Sterility assurance requirements for injection products
What is the Orange Book status of ANECTINE, and who could supply a generic?
Featured snippet answer: Not answerable because the active ingredient and reference listing for “ANECTINE” are not verified here.
What to check in the US (if product identity is confirmed)
- Reference listed drug (RLD) name
- Whether ANDA applicants list the same active ingredient and strength
- Whether 505(b)(2) or 505(j) pathways apply
- Exclusivity (3-year/5-year) and listed patents
What EU medicines register data exists for ANECTINE, and which manufacturers are listed?
Featured snippet answer: Cannot be provided without confirmed EMA or national marketing authorization identifiers for the specific ANECTINE product.
EU supply mapping typically depends on
- Marketing authorization holder (MAH)
- Manufacturing sites for product and batch release
- Parallel distribution participation, if any
- Batch release location and QP sign-off site
Which companies supply ANECTINE at scale: hospital tenders and distributor networks?
Featured snippet answer: Not enough product identity to build a verified distributor and tender supplier list.
Procurement signals that normally identify suppliers
- Tender documents by country and tender class
- Logistics contracts for ampoule/vial formats
- Tender-specific packaging and label configurations
- VAT and product code alignment to the local authorization
Key Takeaways
- A supplier profile for “ANECTINE” cannot be produced from the current input because the drug’s exact product identity is not verified (active ingredient, strength, and market).
- Supplier lists for brand/injection products are highly market-specific and can be materially wrong when trade names collide across regions or actives.
FAQs
- How can I identify the real API behind the brand name ANECTINE in my country?
- Which document shows the manufacturing site for an injection brand like ANECTINE?
- Do aseptic fill-finish suppliers change between strengths or presentations for the same brand?
- What registry fields determine whether an applicant’s API supplier is acceptable for approval?
- How do tender specifications (vial vs ampoule, strength, label language) affect eligible suppliers?
References (APA)
No sources cited.
